GMRE241220C15000
- 0.00
- 0.000.00%
Global Medical REIT Inc Newsroom
JMP Securities Maintains Global Medical REIT Inc(GMRE.US) With Hold Rating
Colliers Securities Maintains Global Medical REIT Inc(GMRE.US) With Buy Rating, Maintains Target Price $10
Strategic Growth and Financial Stability Support Buy Rating for Global Medical REIT
BMO Capital Maintains Global Medical REIT Inc(GMRE.US) With Hold Rating, Maintains Target Price $10
Cautious Outlook on Global Medical REIT: Hold Rating Amid Financial Misses and Leverage Concerns
Berenberg Bank Initiates Global Medical REIT Inc(GMRE.US) With Buy Rating, Announces Target Price $11.75
A. G. P. Initiates Global Medical REIT Inc(GMRE.US) With Buy Rating, Announces Target Price $12
KeyBanc Maintains Global Medical REIT Inc(GMRE.US) With Hold Rating
JMP Securities Maintains Global Medical REIT Inc(GMRE.US) With Hold Rating
JMP Securities Sticks to Its Hold Rating for Global Medical REIT (GMRE)
Global Medical REIT: A Hold Rating Amid Tenant Bankruptcy and Strategic Deals
Analysts Offer Insights on Real Estate Companies: Re/Max Holdings (RMAX), Ryman (RHP) and Global Medical REIT (GMRE)
Buy Rating Affirmed: Strategic Focus and Solid Financials Position Global Medical REIT for Growth
BMO Capital Maintains Global Medical REIT Inc(GMRE.US) With Hold Rating, Maintains Target Price $10
Global Medical REIT: A Cautious Hold Amid Financial Uncertainties and Growth Concerns
B. Riley Securities: Maintaining the Global Medical REIT (GMRE.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $11.00 to $10.00.
Global Medical REIT Analyst Ratings
B. Riley Securities Adjusts Global Medical REIT's Price Target to $10 From $11, Keeps Buy Rating
Global Medical REIT: A Balanced Outlook With Hold Rating Amidst Tenant Challenges and Strategic Acquisitions
Analysts Offer Insights on Real Estate Companies: Global Medical REIT (GMRE) and Douglas Emmett (DEI)